Our results showed that only 2.4% of ovarian serous carcinomas had focal MGP expression, which is lower than the reported positivity of GATA3 (~6%, [7, 66]) and TRPS1 (14%, [31]). The gene discussed is GATA3; the disease is ovarian serous carcinoma.